Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double Blind, Metronidazole Controlled, Dose Range Finding Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

NCT00417872 is registered in ClinicalTrials.gov with Romark Laboratories L.C. as lead sponsor.

NCT NCT00417872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double Blind, Metronidazole Controlled, Dose Range Finding Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
Lead sponsor
Romark Laboratories L.C.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2004
Completion date
September 30, 2005
Enrollment
114
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile